LH inks new agreement to acquire BioReference Health's oncology and related clinical testing services businesses.

This was the stock's sixth consecutive day of losses.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Labcorp will acquire BioReference Health's oncology diagnostics operations as the lab company works to expand in high-growth ...

Nearly a year after Labcorp struck a deal for certain diagnostics assets from BioReference Health, the lab-testing giant is back to buy the firm’s cancer tests. Labcorp is paying $192.5 million ...

The independent laboratory company has entered an agreement to acquire BioReference Health's oncology diagnostic services.

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Voyager Therapeutics (VYGR – Research Report), ...

The stock's rise snapped a seven-day losing streak.

Laboratory Corporation of America Holdings (NYSE:LH), commonly known as Labcorp, is a global leader in clinical laboratory services. The company has recently garnered attention from analysts due ...

Charles River Labs (CRL) stock and LabCorp (LH) stock were upgraded and Quest Diagnostics (DGX) stock was downgraded at Citi. Read more here.

Labcorp has entered into an agreement to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO ...

Labcorp (LH) and OPKO Health (OPK) announced that they have entered into an agreement for Labcorp to acquire select assets of BioReference ...